Genetic Technologies Limited
GNTLF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $15 | $23 | $33 | $34 |
| - Cash | $1 | $8 | $12 | $21 |
| + Debt | $1 | $1 | $1 | $0 |
| Enterprise Value | $14 | $16 | $22 | $13 |
| Revenue | $10 | $10 | $9 | $1 |
| % Growth | -6.5% | 12.3% | 590.6% | – |
| Gross Profit | $4 | $6 | $6 | -$0 |
| % Margin | 40.4% | 58.1% | 70.2% | -18% |
| EBITDA | -$11 | -$11 | -$7 | -$7 |
| % Margin | -118.2% | -108.3% | -78.1% | -536.1% |
| Net Income | -$12 | -$12 | -$7 | -$7 |
| % Margin | -124.2% | -113.6% | -77.4% | -530.3% |
| EPS Diluted | -0.091 | -0.12 | -0.077 | -0.083 |
| % Growth | 24.3% | -55.2% | 6.6% | – |
| Operating Cash Flow | -$10 | -$10 | -$6 | -$6 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$1 |
| Free Cash Flow | -$10 | -$10 | -$6 | -$7 |